We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Universal Health (UHS) Q1 Earnings & Revenues Lag Estimates
Read MoreHide Full Article
Universal Health Services Inc. (UHS - Free Report) reported first-quarter 2018 adjusted earnings of $2.45 per share, missing the Zacks Consensus Estimate by 5.4%. However, the bottom line grew 17% year over year.
Net revenues increased 2.9% year over year to $2.7 billion. However, the top line lagged the Zacks Consensus Estimate by 2%.
Total operating expenses of $2.4 billion at the end of the first quarter also increased 4.2% year over year.
Segment Update
Acute Care Hospitals:
Adjusted admissions and adjusted patient days increased 2.3% and 5.4%, respectively, from the prior-year quarter. Net revenues (on a same facility basis) climbed 3.7% in the first quarter.
Behavioral hospitals:
On a same facility basis, adjusted admissions increased 1.6% while adjusted patient days declined 0.4%, both on a year-over-year basis. Net revenues increased 3% during the quarter under review on a same facility basis.
Universal Health Services, Inc. Price, Consensus and EPS Surprise
As of Mar 31, 2018, the company had cash and cash equivalents of nearly $73 million, down 1.3% from year-end 2017.
Total assets were $11 billion as of Mar 31, 2018, up 2.4% from year-end 2017.
The company managed to lower its debt burden, evident from its long-term debt of $3.4 billion as of Mar 31, 2018, which declined 4% from year-end 2017.
For the first three months of2018, net cash provided by operating activities totaled $364 million, down 24.7% year over year.
Buyback Program
In November 2017, the board of directors authorized a $400-million increase in Universal Health’s stock repurchase program, raising the aggregate authorization to $1.2 billion from the previous $800 million approved in 2016 and 2014.
Concurrently, during the first quarter, the company repurchased 42,000 shares at an aggregate cost of $4.6 million.
Among other players in the Medical sector having reported first-quarter earnings so far, Novartis AG (NVS - Free Report) , UnitedHealth Group Incorporated (UNH - Free Report) and Abbott Laboratories (ABT - Free Report) surpassed the respective Zacks Consensus Estimate.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Universal Health (UHS) Q1 Earnings & Revenues Lag Estimates
Universal Health Services Inc. (UHS - Free Report) reported first-quarter 2018 adjusted earnings of $2.45 per share, missing the Zacks Consensus Estimate by 5.4%. However, the bottom line grew 17% year over year.
Net revenues increased 2.9% year over year to $2.7 billion. However, the top line lagged the Zacks Consensus Estimate by 2%.
Total operating expenses of $2.4 billion at the end of the first quarter also increased 4.2% year over year.
Segment Update
Acute Care Hospitals:
Adjusted admissions and adjusted patient days increased 2.3% and 5.4%, respectively, from the prior-year quarter. Net revenues (on a same facility basis) climbed 3.7% in the first quarter.
Behavioral hospitals:
On a same facility basis, adjusted admissions increased 1.6% while adjusted patient days declined 0.4%, both on a year-over-year basis. Net revenues increased 3% during the quarter under review on a same facility basis.
Universal Health Services, Inc. Price, Consensus and EPS Surprise
Universal Health Services, Inc. Price, Consensus and EPS Surprise | Universal Health Services, Inc. Quote
Financial Update
As of Mar 31, 2018, the company had cash and cash equivalents of nearly $73 million, down 1.3% from year-end 2017.
Total assets were $11 billion as of Mar 31, 2018, up 2.4% from year-end 2017.
The company managed to lower its debt burden, evident from its long-term debt of $3.4 billion as of Mar 31, 2018, which declined 4% from year-end 2017.
For the first three months of2018, net cash provided by operating activities totaled $364 million, down 24.7% year over year.
Buyback Program
In November 2017, the board of directors authorized a $400-million increase in Universal Health’s stock repurchase program, raising the aggregate authorization to $1.2 billion from the previous $800 million approved in 2016 and 2014.
Concurrently, during the first quarter, the company repurchased 42,000 shares at an aggregate cost of $4.6 million.
Zacks Rank & Performance of Peers
Universal Health currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Among other players in the Medical sector having reported first-quarter earnings so far, Novartis AG (NVS - Free Report) , UnitedHealth Group Incorporated (UNH - Free Report) and Abbott Laboratories (ABT - Free Report) surpassed the respective Zacks Consensus Estimate.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>